Literature DB >> 15800312

Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.

Gretchen G Kimmick1, Bercedis L Peterson, Alice B Kornblith, Jeanne Mandelblatt, Jeffrey L Johnson, Judith Wheeler, Robin Heinze, Harvey J Cohen, Hyman B Muss.   

Abstract

PURPOSE: To design and test a geriatric educational intervention to improve accrual of cancer patients age 65 years and older to cooperative group-sponsored treatment trials.
METHODS: Main member institutions of the Cancer and Leukemia Group B (CALGB) and its affiliates were randomly assigned to receive standard information (n = 73) or educational intervention (n = 53). Standard information included CALGB Web site access and periodic notification about existing trials. The geriatric educational intervention included standard information plus: (1) an educational seminar; (2) educational materials; (3) a list of available protocols for use on charts; (4) a monthly e-mail and mail reminders for 1 year; and (5) a case discussion seminar. The main outcome was percentage of accrual of older persons to phase II and III treatment protocols after study initiation compared with baseline.
RESULTS: There were 3,032 patients entered onto trials in the baseline year, and 2,160 and 1,239 during the 2 years postintervention, respectively. Overall percentage of accrual of older patients was 37% at baseline, and 33% and 31% during the first and second years after intervention. There was no improvement in accrual in the intervention versus control arm: 36% v 32% in the first year and 31% v 31% in the second year.
CONCLUSION: Accrual of older patients was not increased by this intervention. Reasons for lack of effect include low intervention intensity, high baseline accrual rates, and closure of several high-accruing protocols during the study. More intense and multifaceted approaches will be needed to change physician (and patient) behavior and to increase accrual of older persons to clinical trials.

Entities:  

Mesh:

Year:  2005        PMID: 15800312     DOI: 10.1200/JCO.2005.01.222

Source DB:  PubMed          Journal:  J Clin Oncol        ISSN: 0732-183X            Impact factor:   44.544


  47 in total

1.  Overturning barriers will take heavy lifting.

Authors:  Harvey Jay Cohen
Journal:  J Oncol Pract       Date:  2008-07       Impact factor: 3.840

2.  Age disparity in the dissemination of imatinib for treating chronic myeloid leukemia.

Authors:  Charles L Wiggins; Linda C Harlan; Harold E Nelson; Jennifer L Stevens; Cheryl L Willman; Edward N Libby; Robert A Hromas
Journal:  Am J Med       Date:  2010-08       Impact factor: 4.965

3.  Geriatric oncology: an overview of progresses and challenges.

Authors:  Martine Extermann
Journal:  Cancer Res Treat       Date:  2010-06-30       Impact factor: 4.679

Review 4.  Cardiovascular complications of breast cancer therapy in older adults.

Authors:  Chetan Shenoy; Igor Klem; Anna Lisa Crowley; Manesh R Patel; Mark A Winchester; Cynthia Owusu; Gretchen G Kimmick
Journal:  Oncologist       Date:  2011-07-07

Review 5.  Cancer Research in the Arab World: A review of publications from seven countries between 2000-2013.

Authors:  Randah R Hamadeh; Saif M Borgan; Abla M Sibai
Journal:  Sultan Qaboos Univ Med J       Date:  2017-06-20

6.  Acute myeloid leukemia and myelodysplastic syndrome after adjuvant chemotherapy: A population-based study among older breast cancer patients.

Authors:  Aron S Rosenstock; Jiangong Niu; Sharon H Giordano; Hui Zhao; Antonio C Wolff; Mariana Chavez-MacGregor
Journal:  Cancer       Date:  2017-12-13       Impact factor: 6.860

7.  Implementing a geriatric assessment in cooperative group clinical cancer trials: CALGB 360401.

Authors:  Arti Hurria; Constance T Cirrincione; Hyman B Muss; Alice B Kornblith; William Barry; Andrew S Artz; Linda Schmieder; Rafat Ansari; William P Tew; Douglas Weckstein; Jeffrey Kirshner; Kayo Togawa; Kurt Hansen; Vani Katheria; Richard Stone; Ilene Galinsky; John Postiglione; Harvey Jay Cohen
Journal:  J Clin Oncol       Date:  2011-02-28       Impact factor: 44.544

8.  Utility of a chemotherapy toxicity prediction tool for older patients in a community setting.

Authors:  C Mariano; R Jamal; P Bains; S Hejazi; L Chao; J Wan; J Ho
Journal:  Curr Oncol       Date:  2019-08-01       Impact factor: 3.677

9.  What leads Indians to participate in clinical trials? A meta-analysis of qualitative studies.

Authors:  Jatin Y Shah; Amruta Phadtare; Dimple Rajgor; Meenakshi Vaghasia; Shreyasee Pradhan; Hilary Zelko; Ricardo Pietrobon
Journal:  PLoS One       Date:  2010-05-20       Impact factor: 3.240

Review 10.  Strategies for increasing recruitment to randomised controlled trials: systematic review.

Authors:  Patrina H Y Caldwell; Sana Hamilton; Alvin Tan; Jonathan C Craig
Journal:  PLoS Med       Date:  2010-11-09       Impact factor: 11.069

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.